Correlation Between Scopus Biopharma and Defence Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Defence Therapeutics, you can compare the effects of market volatilities on Scopus Biopharma and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Defence Therapeutics.
Diversification Opportunities for Scopus Biopharma and Defence Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scopus and Defence is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Defence Therapeutics go up and down completely randomly.
Pair Corralation between Scopus Biopharma and Defence Therapeutics
Given the investment horizon of 90 days Scopus Biopharma is expected to generate 3.01 times more return on investment than Defence Therapeutics. However, Scopus Biopharma is 3.01 times more volatile than Defence Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Defence Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 25.00 in Scopus Biopharma on September 3, 2024 and sell it today you would lose (15.00) from holding Scopus Biopharma or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 7.86% |
| Values | Daily Returns |
Scopus Biopharma vs. Defence Therapeutics
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Defence Therapeutics |
Scopus Biopharma and Defence Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and Defence Therapeutics
The main advantage of trading using opposite Scopus Biopharma and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
| Defence Therapeutics vs. Therapeutic Solutions International | Defence Therapeutics vs. Alpha Cognition | Defence Therapeutics vs. Vg Life Sciences | Defence Therapeutics vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |